Your cart is currently empty!
Category: Kaposi’s Sarcoma
Pomalidomide
Description
This page contains brief details about the drug pomalidomide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Pomalidomide is an antiangiogenic agent (a drug that blocks the formation of blood vessels) which was approved for its medical use on 8th February 2013.
Mechanism of Action of Pomalidomide
Pomalidomide is an antiangiogenic agent that is a derivative of thalidomide. Pomalidomide works by inhibiting the formation of blood vessels that supplies nutrition to the cancer cells and facilitates the immune system attack against cancer cells. It arrests the cell cycle and induces programmed cell death of cancer cells.
Uses of Pomalidomide
Pomalidomide has been developed to treat Multiple myeloma and Kaposi’s sarcoma. It is effective against cancer cells that are resistant against Lenalidomide.
Pomalidomide Dosage available Pomalidomide is available in the form of tablet and capsule in the doses 1mg, 2mg and 4mg. You shall take Pomalidomide with or without food by swallowing the tablet or capsule with water once a day. If you are on hemodialysis treatment, take Pomalidomide after hemodialysis on dialysis days.
Vinblastine
Description
This page contains brief details about the drug vinblastine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Vinblastine is an anticancer drug that belongs to the category of medicines known as mitotic inhibitors. It was approved by the U.S. FDA in the year 1962 to treat Hodgkin’s and non-Hodgkin’s lymphoma.
Mechanism of Action of Vinblastine
It works by disrupting the formation of microtubules in cells. Microtubules are structures that help to support and shape cells, as well as transport molecules within cells. In cancer cells, microtubules play a key role in cell division and growth. By interfering with microtubule formation, this drug disrupts the ability of cancer cells to divide and grow, ultimately leading to their death.
Uses of Vinblastine
Vinblastine is used to treat Hodgkin’s and non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and kaposi’s sarcoma.
Vinblastine Dosage available
The medicine will be administered to you by a healthcare professional in a hospital setting. Vinblastine is given as an injection into a vein (intravenous infusion) over a period of 30 minutes, once a day for up to 5 days. The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors.